We use cookies for a better user experience. Read our Privacy Policy
I Agree
Neuroscience Market
Neuroscience relates to more than one branch of science, such as linguistics, computation, philosophy, psychology, and chemistry. The study for neuroscience includes cellular, operative, behavioral, molecular, evolutionary, and therapeutic aspects of the neurotic system. The neuroscience market includes several technologies that are used for imaging the nervous system. Owing to the accuracy of devices used by neuroscientists, the neuroscience market is expected to grow during the forecast period. The segment involves multiple technologies such as proteomic and neuro-microscopy. Proteomic technologies have crucial applications in neuroscience and their demand is growing rapidly due to their easy availability. The advancement in technology is contributing to the progress of neuro-microscopy, helping in the growth of the neuroscience market. Moreover, there have been many advancements in brain tech, and the ongoing research for better results and accuracy are some of the key factors contributing to market growth.
Request a sample to get extensive insights into the Neuroscience Market
The escalating incidents of neurological complications, which include Alzheimer’s, Parkinson’s, and other brain-related dysfunctions are anticipated to encourage stakeholders in the neuroscience market to help fight such diseases. In 2018, more than one hundred thousand deaths were recorded due to Alzheimer's in the U.S. The Government is increasing the medical expenditure to help improve medical facilities in neuroscience resulting in the expansion of the neuroscience market.
According to the report 'The burden of neurological diseases in Europe', in 2017, the WHO European region recorded more than a million deaths due to neurological diseases. It concluded toward a heavy demand for the development of neuroscience. The medical devices industry has witnessed rapid growth due to technical advancements in recent years. Hence, the global neuroscience market is projected to grow at a CAGR of ~4% from 2021 to 2031.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Presently, laser helmets are being used to calculate brain activity. A laser helmet operates by sending the laser beams into the brain to calculate oxygen levels. This helps to identify the mental process and is currently being called functional near-infrared spectroscopy. Kernel flow helmet began its sale to scientists and researchers this year. The demand for the product is expected to grow in the near future and contribute to the expansion of the neuroscience market.
Another medical science device helping neuroscientists is studded with electrodes to detect tiny nerve impulses on the wrist. The electrode bracelet uses electromyography to monitor signals that travel from the brain to hand muscles. The technology is currently developing with various institutions working on it. Once launched, the devices are likely to witness high demand from various developed economies, fueling the global market for neuroscience.
The increasing number of brain-related disorders and the number of developed healthcare systems are evaluated to hold dominance in the overall market. There are numerous organizations, multiversity, and institutes in North America that are focused on several initiatives and functions to encourage R&D in neuroscience. Moreover, the number of deaths in the U.S. is a cause of concern among governing bodies. Hence, there has been a surge in government funding to help the neuroscience market to grow.
Due to the growing population in Asia Pacific, there is an increased awareness among people about different neurological disorders. The market is witnessing a rise in healthcare expenditure in countries such as India, China, and Japan. The market in Asia Pacific is expected to expand rapidly during the forecast period. Other major factors, including pervasiveness of various neurological diseases are likely to fuel the demand for innovative diagnosis and effective treatment. This is set to propel the market for neuroscience.
In previous years, influenced by the research and development in neuroscience, the limits within various practices dimmed. Technology for brain imaging can allow a biological perspicacity into mental illnesses, which results in faster analysis, more accurate diagnosis, and enhanced monitoring of patient progress over time. Moreover, many neuroscientists and large organizations are spreading awareness and knowledge through events regarding the brain system in public as well government offices.
Many countries have regulations against the use of animals for research and testing. Animals are needed for testing some neurological devices, which can limit the growth of the neuroscience market. However, scientists can use Vitro methods (using human cells and tissues), or Silico models (computer-modeling techniques) for research to overcome the restraining factors related to animal use.
One of the enduring challenges is the ongoing COVID-19 pandemic that is limiting many types of physical applications of neuroscience. The risk of catching a virus is restricting many individuals to assess their symptoms. It is also hampering the research and tests for upgraded devices. Thus, COVID-19 is expected to hinder the growth of the market. However, the rapid development of vaccines to fight the virus is helping the neuroscience market to steadily grow in the upcoming years. Additionally, there is an increasing health consciousness among people resulting in increased demand for mental and physical health check-up devices. These factors are expected to drive the market during the forecast period.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Neuroscience Market
Analysts’ Viewpoint
The ever-rising demand for healthcare and technological headways in neuroscience assures growth of the neuroscience market during the forecast period. The ongoing development in neurotic research and technologies such as whole-brain imaging is boosting the market across multiple continents. The present market is dominated by North America and Europe. However, Asia Pacific is expected to surpass other regions during the forecast period. Additionally, government-involved activities and funding are likely to raise awareness about brain diseases, assuring an increased growth of the global neuroscience market. Major factors including high-cost instruments and animal testing can hamper the growth of the neuroscience market. However, as the production increases, companies are anticipated to reduce prices, and with the technological alternatives to animal tests, the neuroscience market is estimated to rapidly grow during the forecast period.
Neuroscience Market – Segmentation
| Technology |
|
| Component |
|
| End User |
|
| Region |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
The global neuroscience market was worth US$ 28.5 Bn and is projected to reach a value of US$ 41.6 Bn by the end of 2031
Neuroscience market is anticipated to grow at a CAGR of 4% during the forecast period
North America accounted for a major share of the global neuroscience market
Increasing health consciousness among people resulting in increased demand for mental and physical health check-up devices. These factors are expected to drive the neuroscience market during the forecast period
Key players in the global neuroscience market include Doric Lenses, GE Healthcare, Siemens Healthineers, Laserglow Technologies, Mightex Systems, NEURALINK, Kernel, BrainCo, Inc., MindMaze, Paradromics, NeuroPro, NeuroSky, EMOTIV, Cercare Medical A/S, Plexon, Inc., Noldus Information Technology bv, Femtonics Ltd., Neuralynx
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neuroscience Market
4. Market Overview
4.1. Introduction
4.1.1. End-user Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neuroscience Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Overview and Advancements: Brain Computer Interface
5.2. Research Trends of Mind Uploading
5.3. Technological Advancements
5.4. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid /long term impact)
6. Global Neuroscience Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Technology, 2017–2031
6.3.1. Whole Brain Imaging
6.3.2. Neuro-microscopy
6.3.3. Electrophysiology
6.3.4. Neuroproteomic Analysis
6.3.5. Animal Behavior Analysis
6.3.6. Neuro-functional Analysis
6.3.7. Others
6.4. Market Attractiveness Analysis, by Technology
7. Global Neuroscience Market Analysis and Forecast, by Component
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Component, 2017–2031
7.3.1. Instrument
7.3.2. Software
7.3.3. Services
7.4. Market Attractiveness Analysis, by Component
8. Global Neuroscience Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Academic & Research Institutions
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Neuroscience Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Neuroscience Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technology, 2017–2031
10.2.1. Whole Brain Imaging
10.2.2. Neuro-microscopy
10.2.3. Electrophysiology
10.2.4. Neuroproteomic Analysis
10.2.5. Animal Behavior Analysis
10.2.6. Neuro-functional Analysis
10.2.7. Others
10.3. Market Value Forecast, by Component, 2017–2031
10.3.1. Instrument
10.3.2. Software
10.3.3. Services
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Academic & Research Institutions
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By Component
10.6.3. By End-user
10.6.4. By Country
11. Europe Neuroscience Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2017–2031
11.2.1. Whole Brain Imaging
11.2.2. Neuro-microscopy
11.2.3. Electrophysiology
11.2.4. Neuroproteomic Analysis
11.2.5. Animal Behavior Analysis
11.2.6. Neuro-functional Analysis
11.2.7. Others
11.3. Market Value Forecast, by Component, 2017–2031
11.3.1. Instrument
11.3.2. Software
11.3.3. Services
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Academic & Research Institutions
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By Component
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Neuroscience Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2017–2031
12.2.1. Whole Brain Imaging
12.2.2. Neuro-microscopy
12.2.3. Electrophysiology
12.2.4. Neuroproteomic Analysis
12.2.5. Animal Behavior Analysis
12.2.6. Neuro-functional Analysis
12.2.7. Others
12.3. Market Value Forecast, by Component, 2017–2031
12.3.1. Instrument
12.3.2. Software
12.3.3. Services
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Academic & Research Institutions
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Component
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Neuroscience Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2017–2031
13.2.1. Whole Brain Imaging
13.2.2. Neuro-microscopy
13.2.3. Electrophysiology
13.2.4. Neuroproteomic Analysis
13.2.5. Animal Behavior Analysis
13.2.6. Neuro-functional Analysis
13.2.7. Others
13.3. Market Value Forecast, by Component, 2017–2031
13.3.1. Instrument
13.3.2. Software
13.3.3. Services
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Academic & Research Institutions
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By Component
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Neuroscience Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2017–2031
14.2.1. Whole Brain Imaging
14.2.2. Neuro-microscopy
14.2.3. Electrophysiology
14.2.4. Neuroproteomic Analysis
14.2.5. Animal Behavior Analysis
14.2.6. Neuro-functional Analysis
14.2.7. Others
14.3. Market Value Forecast, by Component, 2017–2031
14.3.1. Instrument
14.3.2. Software
14.3.3. Services
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Academic & Research Institutions
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technology
14.6.2. By Component
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Rank Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. NEURALINK
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. Kernel
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis
15.3.3. BrainCo, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. MindMaze
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Paradromics
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. NeuroPro
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. NeuroSky
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. EMOTIV, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9. Cercare Medical A/S
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Growth Strategies
15.3.9.3. SWOT Analysis
15.3.10. Plexon, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
15.3.11. Noldus Information Technology B.V.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Growth Strategies
15.3.11.3. SWOT Analysis
15.3.12. Femtonics Ltd.
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Growth Strategies
15.3.12.3. SWOT Analysis
15.3.13. Neuralynx, Inc.
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Growth Strategies
15.3.13.3. SWOT Analysis
15.3.14. Neurable, Inc.
15.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.14.2. Growth Strategies
15.3.14.3. SWOT Analysis
15.3.15. Bitbrain Technologies
15.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.15.2. Growth Strategies
15.3.15.3. SWOT Analysis
15.3.16. Halo Neuroscience
15.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.16.2. Growth Strategies
15.3.16.3. SWOT Analysis
15.3.17. NeuroNexus Technologies, Inc.
15.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.17.2. Growth Strategies
15.3.17.3. SWOT Analysis
List of Tables
Table 01: Global Neuroscience Market Value (US$ Mn) Forecast, by Technology, 2017–2031
Table 02: Global Neuroscience Market Value (US$ Mn) Forecast, by Component, 2017–2031
Table 03: Global Neuroscience Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Neuroscience Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Neuroscience Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Neuroscience Market Value (US$ Mn) Forecast, by Technology, 2017–2031
Table 07: North America Neuroscience Market Value (US$ Mn) Forecast, by Component, 2017–2031
Table 08: North America Neuroscience Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Neuroscience Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Neuroscience Market Value (US$ Mn) Forecast, by Technology, 2017–2031
Table 11: Europe Neuroscience Market Value (US$ Mn) Forecast, by Component, 2017–2031
Table 12: Europe Neuroscience Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, by Technology, 2017–2031
Table 15: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, by Component, 2017–2031
Table 16: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Neuroscience Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 18: Latin America Neuroscience Market Value (US$ Mn) Forecast, by Technology, 2017–2031
Table 19: Latin America Neuroscience Market Value (US$ Mn) Forecast, by Component, 2017–2031
Table 20: Latin America Neuroscience Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Neuroscience Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Neuroscience Market Value (US$ Mn) Forecast, by Technology, 2017–2031
Table 23: Middle East & Africa Neuroscience Market Value (US$ Mn) Forecast, by Component, 2017–2031
Table 24: Middle East & Africa Neuroscience Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Neuroscience Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Neuroscience Market Value Share, by Technology, 2020
Figure 03: Global Neuroscience Market Value Share, by Component, 2020
Figure 04: Global Neuroscience Market Value Share, by End-user, 2020
Figure 05: Global Neuroscience Market Value Share, by Region, 2020
Figure 06: Global Neuroscience Market Value Share Analysis, by Technology, 2020 and 2031
Figure 07: Global Neuroscience Market Attractiveness Analysis, by Technology, 2021–2031
Figure 08: Global Neuroscience Market Value (US$ Mn), by Whole Brain Imaging, 2017–2031
Figure 09: Global Neuroscience Market Value (US$ Mn), by Neuro-microscopy, 2017–2031
Figure 10: Global Neuroscience Market Value (US$ Mn), by Electrophysiology, 2017–2031
Figure 11: Global Neuroscience Market Value (US$ Mn), by Neuroproteomic Analysis, 2017–2031
Figure 12: Global Neuroscience Market Value (US$ Mn), by Animal Behavior Analysis, 2017–2031
Figure 13: Global Neuroscience Market Value (US$ Mn), by Neuro-functional Analysis, 2017–2031
Figure 14: Global Neuroscience Market Value (US$ Mn), by Others, 2017–2031
Figure 15: Global Neuroscience Market Value Share Analysis, by Component, 2020 and 2031
Figure 16: Global Neuroscience Market Attractiveness Analysis, by Component, 2021–2031
Figure 17: Global Neuroscience Market Value (US$ Mn), by Instrument, 2017–2031
Figure 18: Global Neuroscience Market Value (US$ Mn), by Software, 2017–2031
Figure 19: Global Neuroscience Market Value (US$ Mn), by Services, 2017–2031
Figure 20: Global Neuroscience Market Value Share Analysis, by End-user, 2020 and 2031
Figure 21: Global Neuroscience Market Attractiveness Analysis, by End-user, 2021–2031
Figure 22: Global Neuroscience Market Value (US$ Mn), by Hospitals, 2017–2031
Figure 23: Global Neuroscience Market Value (US$ Mn), by Diagnostic Laboratories, 2017–2031
Figure 24: Global Neuroscience Market Value (US$ Mn), by Academic & Research Institutions, 2017–2031
Figure 25: Global Neuroscience Market Value (US$ Mn), by Others, 2017–2031
Figure 26: Global Neuroscience Market Value Share Analysis, by Region, 2020 and 2031
Figure 27: Global Neuroscience Market Attractiveness Analysis, by Region, 2021–2031
Figure 28: North America Neuroscience Market Value (US$ Mn) Forecast, 2017–2031
Figure 29: North America Neuroscience Market Value Share Analysis, by Country, 2020 and 2031
Figure 30: North America Neuroscience Market Attractiveness Analysis, by Country, 2021–2031
Figure 31: North America Neuroscience Market Value Share Analysis, by Technology, 2020 and 2031
Figure 32: North America Neuroscience Market Attractiveness Analysis, by Technology, 2021–2031
Figure 33: North America Neuroscience Market Value Share Analysis, by Component, 2020 and 2031
Figure 34: North America Neuroscience Market Attractiveness Analysis, by Component, 2021–2031
Figure 35: North America Neuroscience Market Value Share Analysis, by End-user, 2020 and 2031
Figure 36: North America Neuroscience Market Attractiveness Analysis, by End-user, 2021–2031
Figure 37: Europe Neuroscience Market Value (US$ Mn) Forecast, 2017–2031
Figure 38: Europe Neuroscience Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 39: Europe Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 40: Europe Neuroscience Market Value Share Analysis, by Technology, 2020 and 2031
Figure 41: Europe Neuroscience Market Attractiveness Analysis, by Technology, 2021–2031
Figure 42: Europe Neuroscience Market Value Share Analysis, by Component, 2020 and 2031
Figure 43: Europe Neuroscience Market Attractiveness Analysis, by Component, 2021–2031
Figure 44: Europe Neuroscience Market Value Share Analysis, by End-user, 2020 and 2031
Figure 45: Europe Neuroscience Market Attractiveness Analysis, by End-user, 2021–2031
Figure 46: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, 2017–2031
Figure 47: Asia Pacific Neuroscience Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 48: Asia Pacific Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 49: Asia Pacific Neuroscience Market Value Share Analysis, by Technology, 2020 and 2031
Figure 50: Asia Pacific Neuroscience Market Attractiveness Analysis, by Technology, 2021–2031
Figure 51: Asia Pacific Neuroscience Market Value Share Analysis, by Component, 2020 and 2031
Figure 52: Asia Pacific Neuroscience Market Attractiveness Analysis, by Component, 2021–2031
Figure 53: Asia Pacific Neuroscience Market Value Share Analysis, by End-user, 2020 and 2031
Figure 54: Asia Pacific Neuroscience Market Attractiveness Analysis, by End-user, 2021–2031
Figure 55: Latin America Neuroscience Market Value (US$ Mn) Forecast, 2017–2031
Figure 56: Latin America Neuroscience Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 57: Latin America Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 58: Latin America Neuroscience Market Value Share Analysis, by Technology, 2020 and 2031
Figure 59: Latin America Neuroscience Market Attractiveness Analysis, by Technology, 2021–2031
Figure 60: Latin America Neuroscience Market Value Share Analysis, by Component, 2020 and 2031
Figure 61: Latin America Neuroscience Market Attractiveness Analysis, by Component, 2021–2031
Figure 62: Latin America Neuroscience Market Value Share Analysis, by End-user, 2020 and 2031
Figure 63: Latin America Neuroscience Market Attractiveness Analysis, by End-user, 2021–2031
Figure 64: Middle East & Africa Neuroscience Market Value (US$ Mn) Forecast, 2017–2031
Figure 65: Middle East & Africa Neuroscience Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 66: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 67: Middle East & Africa Neuroscience Market Value Share Analysis, by Technology, 2020 and 2031
Figure 68: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Technology, 2021–2031
Figure 69: Middle East & Africa Neuroscience Market Value Share Analysis, by Component, 2020 and 2031
Figure 70: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Component, 2021–2031
Figure 71: Middle East & Africa Neuroscience Market Value Share Analysis, by End-user, 2020 and 2031
Figure 72: Middle East & Africa Neuroscience Market Attractiveness Analysis, by End-user, 2021–2031
Figure 73: Global Neuroscience Market Share/Rank Analysis, by Company, 2020
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
